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Abstract-A deterministic model is proposed for the study of the dynamics of acquired immun- 
odeficiency syndrome (AIDS) and tuberculosis (TB) co-infection. The model is comprised by a set 
of sixteen ordinary differential equations representing different states of both diseases, and it is in- 
tended to provide a theoretical framework for the study of the interaction between both infections. 
Numerical simulations of the model resulted in three striking outcomes: first, the pathogenicity of 
Human Immunodeficiency Virus (HIV) 1s enhanced by the presence of TB, and vice-versa; second, 
the prevalence of AIDS is higher in the presence of TB; and third, relative risk analysis demonstrated 
a much stronger influence of AIDS on TB than the other way around. 
INTRODUCTION 
The steady decline in the annual number of cases of tuberculosis observed in the United States 
since the early fifties reversed dramatically after 1984 [l]. For instance, from 1975 through 1984, 
tuberculosis case rates decreased from 15.9 to 9.4 per 100000 population, an average decline of 
5.7% annually [2]. The number of cases rose by 3 percent in 1986, by 5 percent in 1989, and 
by more than 6 percent in 1990 [3-61. This upheaval in the incidence of tuberculosis has been 
attributed to the human immunodeficiency virus epidemic [l]. 
Overall tuberculosis has been found to occur in 4.2 percent of patients with AIDS in the United 
States [7]. In Canada, studies have shown a total of 15 cases of tuberculosis among 464 AIDS 
patients in the period from 1983 to 1988, giving a prevalence of 3.2 percent [8]. In some American 
inner-city areas, blacks and Hispanics have accounted for between 80 to 100 percent of the cases 
of AIDS and tuberculosis [9]. Data from Florida [lo] indicate a relative odds ratio of tuberculosis 
in patients with AIDS of 3.4, 5.5, and 10.5 when Hispanics, blacks, and Haitians, respectively, are 
compared with non-Hispanic whites. A recent study in New York points out the propensity of HIV 
infection, without AIDS-related disease, to activate remote dormant tuberculosis infection [ll]. 
Therefore, the occurrence of tuberculosis as a sentinel infection in risk groups for HIV infection 
should be stressed, at least for developed countries [12]. 
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Infection with the human immunodeficiency virus causes a progressive and ultimately pro- 
found reduction in the cell-mediated immune response, thus setting the stage for a variety of 
opportunistic infections, including Mycobacterium tuberculosis and avium [13]. 
The interaction of HIV and tuberculosis is well-documented, and the need to understand it has 
been set as a priority in the global program against AIDS [14-161. 
This paper has the objective of providing a theoretical framework aimed at evaluating the 
interaction between AIDS and tuberculosis, upon which biological realities could be taken into 
account, and is organized as follows: after this introduction, we present a section which describes 
the model’s structure, assumptions, and the compartment and parameter definitions. The next 
section presents the equation which describe the model’s dynamics. In the following section, we 
perform a sensibility and equilibrium analysis which is central for the determination of the trans- 
mission parameters. Presented next are the numerical simulations of the model, whose results 
allow an epidemiological analysis intended to quantify the interaction between both infections. 
The final section discusses the paper’s proposals and the model’s implications. 
THE MODEL 
The model proposed has a structure comprised by sixteen compartments representing different 
states of both infections. Two basic versions can be analyzed, one representing a closed popu- 
lation, in the sense that the total population is taken to be constant, mimicking situations like 
prisons or mental institutions, and an open version, in which the total number of individuals is 
taken to be a dynamic variable. Since the qualitative outcomes of both versions are quite similar, 
in this paper, we present only the analysis of the closed one. 
The model assumes a homogeneity mixing pattern of transmission for both infections. Indi- 
viduals are assumed to get HIV infection by all possible manners, a fraction of whom remain so, 
without developing full-blown AIDS in the absence of tuberculosis. It is also assumed that AIDS 
patients are so ill that they are unlikely to transmit the infection. All the active tuberculosis 
cases are assumed to be infective. We consider reinfection by Mycobacterium as a possibility, 
although this is a rare event. 
Figure I shows a block diagram representing the model’s structure whose variables and param- 
eters are summarized by Table 1. We consider two types of susceptible individuals, represented 
by Xl(t), who are susceptible to both infections and X2(t), who are also susceptible to both 
infections but have been infected by Mycobacterium (TB) at least once in the past. Individuals 
acquire the HIV infection with a rate of p individuals per unit of time, and TB infection with a 
rate of X individuals per unit of time. The parameter ,Ll includes implicitly, the way a particular 
subfraction of the susceptible population acquired the infection. So, for instance, in a case where 
the infection occurred via sexual contact, the average number of sexual partners is implicitly 
comprised by p. HIV-positive individuals are represented by the compartments labelled Z(t), 
who remain healthy; Yl(t), w h o will develop the AIDS-Related-Complex syndrome (ARCl(t) and 
(ARC:!(t)) after the incubation period l/yi (i = 1,2); Yz(t), who will develop AIDS (Al(t) and 
AZ(~)) after the incubation period l/wi (i = 1,2); Ys(t), who are HIV-positive and have been 
infected by TB at least once in the part and who will develop AIDS (As(t)) after an incubation 
period 1/w5; and Yd(t), who are HIV-positive and have active tuberculosis disease. The latter 
will develop AIDS (ATbc(t)) ft a er an incubation period l/r. Individuals in the compartment 
labelled ARCp(t) develop full-blown AIDS after a period l/wi (i = 3,4). AIDS patients in the 
compartment labelled Al remain so whilst AZ patients are susceptible to tuberculosis infection, 
acquiring it at a rate X. Patients in the compartment labelled Aa can develop tuberculosis either 
by reinfection, at a rate A”‘, or by reactivation of their primary complex, at rate 0s. 
Once infected by TB, all individuals but Aa and As pass through a transition compartment & 
(i = 1 if from Xj and 2 if from Yk (/c = 1,2,3), 2 or ARCj (j = 1,2)), after which individuals 
either become ill or latent, with rates & and pi (i = 1,2), respectively. Table 1 summarizes the 
variable and parameter definitions. 
It should be pointed out that although HIV+ individuals acquire TB infection with the same 
rate X as the negative ones, they evolve to tuberculosis disease with a rate that is the double 
value as that for the HIV- individuals. This assumption is expressed by the ratio &/pi, whose 
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Figure 1. Flow chart representing the compartmental structure of the model. 
Table 1. Variable and parameter definitions. 
Parameters 
A(t) = immigration rate (closed version) 
A(t) = maternity function open version 
p = transmission rate for HIV 
X = transmission rate for tuberculosis 
yi = inverse of the incubation period for 
ARC 
Variables 
Xi(t) = Susceptible to both infections 
X2(t) = Susceptible with latent tuberculosis 
11 (t) = Infected with tuberculosis 
Z(t) = Healthy seropositive 
Y&1,2(t) = HIV-positive 
q = inverse of the incubation period for 
AIDS 
pi = recovery rate for tuberculosis 
infection and disease 
6i = inverse of the incubation period for 
tuberculosis 
Ya(t) = HIV-positive with latent 
tuberculosis 
Y4(t) = HIV-positive with active 
tuberculosis 
ARCi (t) = AIDS-Related-Complex 
oi = reactivation of tuberculosis disease 12(t) = HIV-positive infected with 
tuberculosis 
< = inverse of the incubation period for Ai=l,2(t) = AIDS 
AIDS with active tuberculosis 
,u = natural mortality rate As(t) = AIDS with latent tuberculosis 
a = AIDS mortality rate Z%(t) = Active tuberculosis 
0 = Tuberculosis mortality rate AZ%(t) = AIDS with active tuberculosis 
values are shown in Table 2. Active cases of tuberculosis can recover spontaneously with a rate 
Pk (k = 3,4,5), and the other way around, latent cases can reactivate with a rate ui (i = 1,2,3). 
Reinfection with TB occurs with rates X’, X”, and X”’ as we consider healthy individuals, HIV- 
positive, and AIDS patients, respectively. 
Individuals enter into the system with a rate a(t), meaning a birth rate for the open and an 
immigration rate for the closed versions of the model. Rates p, Q, and ~9 represent the natural 
mortality, lethality to AIDS, and lethality to tuberculosis, respectively. 
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Table 2. Parameters and initial condition values for the simulation of the closed 
Parameter Initial Condition 
p = 0.40 X1 (0) = 0.662 
x = 1.20 Xz(0) = 0.3 
X’ = 0.0024 11(O) = 0 
A” = 0.0048 Z(0) = 0.007 
X”’ = 0.0096 Yl(0) = 0.007 
yl = 0.1 Yz(0) = 0.007 
^I: = 0.23 Y3(0) = 0.007 
Wl = 0.005 Y4(0) = 0 
w2 = 0.1 ARC1 (0) = 0 
w3 = 0.11 AR&(O) = 0 
w4 = 0.22 Al(O) = 0 
wg = 0.15 AZ(O) = 0 
p1 = 8.0 A3(0) = 0 
p2 = 6.0 Tbc(0) = 0.01 
~3 = 0.8 ATbc(0) = 0 
p4 = 0.5 12(O) = 0 
p5 = 0.2 a(0) = 0.0155 
61 = 0.1 N(0) = 1.0 
62 = 0.15 
CT~ = 0.065 
a2 = 0.1 
03 = 0.33 
< = 0.33 
/L = 0.15 
(Y = 0.33 
I9 = 0.05 
MODEL’S EQUATIONS 
The model’s dynamics are described by a system of non-linear ordinary differential equations, 
in which we call: 
HIV+ = plZ(t) + p2 [K(t) + K(t) + J’3(t) + K(t)] + p3 ARCI + p4 ARCz(t) 
N(t) 
and 
TB = ~5 [Tbc(t) + Y4(t)l + PG AWt) 
N(t) 
The set of equations has the form: 
v = a(t)Xl(O) - X,(t) [@(HIV+) + X(TB) + p] 
y = a(t)X,(O) + PI&(t) + psTbc(t) - X2(t) [al + P(HIV+) + X’(TB) +/A] 
y = (TB) [AXI(t) + A’Xz(t)] - II(t) [PI + 61 + P(HIV+) +/A] 
7 = qXz(t) + 6111(t) - Tbc(t) [PB + P(HIV+) + p + O] 
F = a(t)Z(O) + fX,(t)(HIV+) - Z(t)[X(TB) + p] 
y = u(t)Yl(O) + ;X&)(HIV+) - Yl(t) [n + 72 + X(TB) + p] 
\ 
(1) 
(2) 
(3) 
(4) 
(5) 
(6) 
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dWt> 
- = a(t)Yz(O) + gX&)(HIV+) - Yz(t) [WI + w2 + X(TB) + P] 
dt (7) 
F = a(t)Y3(0) + PX2(t)(HIV+) + p212(t) + P4Y4(t) - Y-3(t) [X”(D) + w5 + 02 + p] 
(8) 
d&(t) 
- = c2Ys(t) +5213(t) + P(HIV+) [11(t) + Z%(t)] - K(t) [p4 + E + P+ 01 
dt (9) 
dAz1(t) = ylYl(t) - ARCl(t)[X(TB) + ~1 (10) 
dAz2(t) = T2Yl(t) - ARC2(t) [X(TB) + w3 + w4 + p] 
(11) 
G(t) 
~ = X(TB) [Z(t) + Yl(t) + ARCl(t) + ARC2(t)] + X”(TB)Y3(t) - 12(t) [S:! + p2 + p] 
dt 
(12) 
y = w1Y3(t) + w3ARC3(t) - Al(t)[p + a] 
dA2 (t) 
(13) 
- = wsYs(t) + wdARCs(t) - Az(t)[X(TB) + p + a] 
dA:(t) 
(14 
- = wgYs(t) + psAtbc(t) - A3(t)[X”‘(TB) + P+ Q + 031 
dt (15) 
dA;;(t) = <Yd(t) + a3A3(t) + x(TB)Ag(t) + X”‘(TB)A&) - ATbc(t)[p + cy + 6’ + ps]. 
(16) 
The closed version assumes a total population N(t) that is a constant and equal to one. 
For this we assume an immigration rate a(t) as an entry into the susceptible and HIV-positive 
compartments (Xl(t), X2(t), z(t), q(t), K(t), and Ya(t)). This immigration rate equals the 
sum of all mortality rates and is weighted by an expected proportion of each of these classes in 
the population as a whole. 
This set of equations can be rewritten to describe the dynamics of the model for an open 
version which could mimick populations with variable size. For this equations (l), (2), (5)-(8) 
are now written as: 
dX1 (t) 
~ = A(t) - Xl(t)[P(HIV+) + X(TB) + p] 
di2’(t) 
~ = plIl(t) + psTbc(t) - X2(t) [al + @HIV+) + X’(TB) + p] 
dt 
F = fX&)(HIV+) - Z(t)[X(TB) + p] 
dK(t) P - = zXl(t)(HIV+) - Y-l(t) [-ye + 72 + X(TB) + p] 
d &) P - = 3X1(t)(HIV+) - Yz(t) [WI + w2 + X(TB) + p] 
dt 
y = PX&)(HIV+) + p&(t) + p&(t) - Ys(t) [x”(TB) + ws + 02 + p] 
(la) 
(24 
(54 
(64 
(74 
(84 
q = A(t) - pN(t) - a [Al(t) + AZ(t) + As(t) + ATbc(t)] - 0 [Tbc(t) + Y4(t) + ATbc(t)], 
(17) 
where 
is a density-dependent maternity function with birth rate IE. 
This function assumes that only individuals form classes X 1, X2, II, and Tbc are able to 
reproduce. 
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SENSITIVITY ANALYSIS 
Of the forty parameters of the model (including some additional proportions rates not presented 
in Table l), a great number can be estimated from epidemiological knowledge of both diseases. 
However, the infection rates for HIV and TB (p and X, respectively) are extremely difficult, if 
not impossible, to estimate directly. The sensitivity and equilibrium analysis techniques could 
provide some insights to the estimation of these parameters, once all the others are known with 
at least some degree of confidence. 
For the situation where there are k functions, given by the column vector z z {xi}, i = 1,. . . , k; 
and p essential parameters indicated by 0 = { 0,}, j = 1, . . . , p, we have that 117) 
6x = H60 (18) 
where 
The matrix H is the sensitivity matrkc, whose individual elements hij are the sensitivity func- 
tions $$. Two additional matrices are required for the sensitive analysis, namely 
Now suppose that the vector B is subject to a multi-dimensional prior distribution, for which 
the covariance matrix is V(0). It follows that the corresponding covariance matrix V(x) for the 
multi-dimensional distribution of the vector x is given by 
V(x) = HV(B)H’ 
where the prime indicates transposition. 
(21) 
Assuming that the elements of V(0) have been derived from subjective prior estimates (171, 
and that all the 0.j are uncorrelated, the covariance matrix V(O) is of diagonal form, namely 
where ~7: = var(ej). 
Substituting (22) into (21) then gives 
var(xj) = f: h5 c$ 
j=l 
(23) 
where the sensitivity matrix is given by 
H = -E-‘T. (24) f 
Therefore, the parameters to which any given xi is most sensitive will maximize var(xi). 
As mentioned above, we derived the elements of V(e) from subjective prior estimates based on 
the current epidemiologic knowledge of both infections. So we performed the sensitivity analysis 
assuming, to begin with, an equal variance for all the model’s parameters and calculated the 
variances of the variables according to equation (23). We also assumed that for the closed version 
of the model, there is no immigration rate to any compartment except the susceptible X1. Under 
these conditions, all the model’s variables showed to be most sensitive to 0, the transmission 
rate for HIV. We then reduced the variance of /3 to zero and recalculated the variables’ variances 
in order to estimate which would be the next parameter to which the model is most sensitive. 
We repeated this procedure until the last parameter. Table 3 shows the results of this analysis 
for A, the transmission rate of tuberculosis. It is interesting to note that the model is practically 
insensitive to variations in X. Only in the gth iteration, the first variable (Xl) presented its 
maximum variance for this parameter. 
AIDS and tuberculosis 
Table 3. Results of the sensitivity analysis for the parameter X, the force of infection 
tuberculosis. Shown is the iteration number and the variable whose variance is 
maximized by changes in X. 
Variable 
xl(t) 
A1 (t) 
Az(t) 
As(t) 
Tbc( t) 
ARG(t) 
X,(t) 
z(t) 
yl(t) 
K(t) 
:2(t) 
Iteration 
9th 
11th 
11th 
12th 
14th 
14th 
17th 
lgth 
19th 
19th 
20th 
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EQUILIBRIUM ANALYSIS 
Next we performed the equilibrium analysis. As the analytical solution for the equilibrium 
densities is not straightforward, we simulated the model numerically with all the parameters’ 
values fixed, except for p and X. For this we applied the Newton-Raphson method [18], which is 
basically an iterative solution of the equation 
f(xi+sX)=f(xo)+ $1 7 6X=0 
X0 
where the vector f(Xi) is the right side of equations (l)-(16). The increment SX is then 
ax=- af -l 
[ 1 ax X0 f (X0). (26) 
The first solution for Xi is given by 2 = 0. Successive iterations are then performed by 
calculating 
Xi+1 = XifSX (27) 
in equation (25) until the difference between {Xci+r) - Xz} is lower than a given criterium. This 
method allows the estimation of all the equilibrium solutions for equations (l)-(16) for a given 
set of parameters. 
If we take either p, or X, or both parameters as equal to zero, we have the trivial solution, 
that is, the absence of either (or both) disease. By calculating the eigenvalues of the Jacobian 
matrix associated with the system of equations (l)-( 16), we can determine the stability of these 
equilibrium solutions. In case either /3 or X (or both) are zero, i.e., the absence of either (or both) 
diseases, we have that all the eigenvalues have their real parts negatives, characterizing a stable 
equilibrium [19]. We then raise slowly the values of either p or X (or both) until the stability of 
the trivial solution is broken, that is, when at least one of the real part of the eigenvalues of the 
Jacobian matrix turns to positive. This value of the parameter represents a threshold point, above 
which the disease persists, below which the disease disappears. They represent the infection rates 
that guarantee the Basic Reproductive Rates [20] to be greater than one. The threshold values 
found for these conditions and set of parameters are p = 0.245 and X = 1.013. The numerical 
solution for the equilibrium proportion of individuals and their respective eigenvalues, calculated 
with the set of parameters shown in Table 2, in the absence of immigration except for Xr, can 
be seen in Table 4. 
MY 17:9-B 
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Table 4. Numerical solution for the equilibrium proportion of the individuals and 
their respective eigenvalues. 
Variable 
Xl 
x2 
I1 
Tbc 
z 
K 
y2 
y3 
Y4 
ARCI 
ARC2 
AI 
A2 
A3 
ATbc 
12 
Equilibrium Value Eigenvalue 
0.220705 -8.130815 + 0.00000 i 
0.636428 -6.165702 + 0.00000 i 
0.000485 -1.588609 + 0.00000 i 
0.014546 -0.896678 - 0.00394 i 
0.029969 -0.896678 - 0.00394 i 
0.002708 -0.533974 + 0.00000 i 
0.005855 -0.170276 + 0.00000 i 
0.049317 -0.015750 - 0.00551 i 
0.002032 -0.015750 + 0.00551 i 
0.008261 -0.046226 - 0.00624 i 
0.001717 -0.046226 + 0.00624 i 
0.001311 -0.336779 - 0.02918 i 
0.002494 -0.336779 + 0.02918 i 
0.013034 -0.382691 - 0.00112 i 
0.010715 -0.382691+ 0.00112 i 
0.000140 -0.032788 + 0.00000 i 
SIMULATIONS OF THE MODEL 
In order to study the model’s dynamics, we performed numerical simulations for both the 
open and closed versions. As mentioned above, since the qualitative omcomes of either versions 
are very similar, we shall present in this paper only the results of the closed one. Information 
on the main epidemiological parameters determining transmission is slowly accumulating, but 
much uncertainty remains. The major features of HIV infection and disease culled from some 
of the more extensive studies have been recently reviewed by Anderson et al. [21]. For the 
estimation of the set of parameters required for the simulation here performed, we applied the 
“Method of Varying Parameters to Match the Data,” described by Kault and Marsh [22], along 
with the equilibrium analysis described above, which resulted in plausible values for current 
epidemiological knowledge. 
In this set of simulations, we study the relative distribution of individuals among susceptible, 
asymptomatic carriers and those with active disease for both infections. We are particularly 
interested in demonstrating the mutual influence of both infections. 
Figure 2 shows the time variation of the ratio between the proportion of AIDS cases and HIV- 
positive individuals. The lower curve represents this ratio in the absence of tuberculosis, whilst 
the upper one represents the same ratio in the presence of both infections. It can be noted that 
in the presence of tuberculosis there is a marked increase in the relative proportion of AIDS cases 
as related to total HIV infection. 
Figure 3 shows a similar analysis for the ratio between the proportions of active and latent 
cases of tuberculosis in the absence and presence of HIV infection for the lower and upper curves, 
respectively. Again there is a substantial increase in the relative amount of active tuberculosis 
in the presence of AIDS. 
In Figure 4, it is shown how the prevalence of AIDS varies as a function of tuberculosis in- 
cidence. The lower curve represents the time variation of AIDS prevalence in the absence of 
tuberculosis. The set of upper curves shows the increase in AIDS prevalence with growing tuber- 
culosis incidence. 
The equivalent situation is shown in Figure 5, which displays the time variation in the preva- 
lence of tuberculosis as a function of HIV incidence. It can be noted that, similarly to Figure 4, 
there is an increase in tuberculosis prevalence with growing values of HIV incidence. 
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Figure 2. Time variation of the ratio AIDS/HIV+ in the absence (lower curve) and 
presence of tuberculosis (upper curve). 
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Figure 3. Time variation of the ratio active/latent TB in the absence (lower curve) 
and presence of AIDS (upper curve). 
ANALYSIS OF THE INTERACTION BETWEEN HIV AND TB 
In this section, we present the results of the epidemiological analysis aiming to quantify the 
interaction between HIV and TB infection as predicted by the model. For this we estimated the 
Relative Risk (RR) [23] of developing AIDS given that one is exposed to TB, and the other way 
around, the RR of developing active TB once exposed to HIV. As we simulated the model for a 
period of 50 years, our results should be expressed by the Incidence Density Ratio, which is the 
most commonly applied indicator of RR in ‘follow-up’ studies [24]. 
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Figure 4. Time variation of AIDS prevalence in the absence of tuberculosis (lower 
curve) and crescent incidence of tuberculosis (upper set of curves). 
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Figure 5. Time variation of TB prevalence in the absence of AIDS (lower curve) and 
crescent incidence of AIDS (upper set of curves). 
The Incidence Density F&tio is defined as the ratio of the number of affected individuals among 
all the exposed to a potential risk factor, to the number of affected individuals among all the 
non-exposed to the same factor [23]. So, in the classical 2 x 2 table of the form: 
exposed non-exposed 
affected A B 
non-affected C D 
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the Incidence Density Ratio would be: 
A 
IDR = (A+C). 
For the estimation of the relative risk of developing AIDS once exposed to TB, we consider the 
total number of AIDS cases and susceptible after fifty years of simulation with the transmission 
rate of TB, X, varying from 0.5 to 2 and 0, for the exposed and non-exposed conditions, respec- 
tively. Figure 6 shows the result of this analysis. It can be noted that the risk of developing 
AIDS in the presence of TB rapidly raises to around 2.5 times greater than in its absence, and 
varies very little with further increases in the values of TB incidence. 
4 
5.5 
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1.5 
1 
0.5 
0 
0 0.2 0.4 0.5 0.5 1 1.2 1.4 1.6 1.5 2 
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Figure 6. Relative risk of developing AIDS as a function of TB incidence. 
By the same token, we consider, for the estimation of the relative risk of developing tuberculosis 
once exposed to HIV, the total number of TB cases and susceptible after fifty years of simulation 
with the transmission rate of HIV, p, varying from 0.05 to 0.6 and 0, for the exposed and non- 
exposed conditions, respectively. The result of this analysis is shown in Figure 7. It can be 
noted that the relative risk of developing tuberculosis once exposed to HIV raises exponentially 
with the increasing in the HIV incidence, from about 1.5 to almost 11 times greater than in 
its absence. This remarkable difference in the model behaviour should be expected from the 
sensitivity analysis results, which demonstrated a greater sensitivity of the model to the HIV 
incidence rate /3, and is in accord with the current epidemiological observations. 
An interesting alternative way to qualitatively understand the interaction between both infec- 
tions is to analyze how the effective reproductive rate, R, varies as a function of the proportion 
of remaining susceptible X(t). The effective reproductive rate is usually defined as the average 
number of secondary infections caused by each infectious individual [20]. It contrasts with the 
basic reproductive rate, Ro, which is defined as the average number of secondary infections pro- 
duced by a single infectious individual in an entirely susceptible population. The effective and 
the basic reproductive rates are related, under the “weak homogeneously mixing” assumption 
by [20]: 
R = RoX(t), (28) 
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Figure 7. Relative risk of developing active TB as a function of AIDS incidence. 
OR 
where X(t) in our model is the sum of Xi(t) + X2(t). Solving equations (1) and (2) for Xr (t) 
and X2(t) we have: 
where 
Fi(t) = [P(HIV+ + CL] + X(TB) 
with a(t), HIV+, and (TB) as defined before and 
x2(t) = [xz(o) + I’ F2(qeJl -s’] et” S@‘T 
(29) 
(30) 
where 
F2(t) = PlIl (t) + p25yt) 
and 
G(t) = 01 -t [P(HIV+ + P] + X’(TB). 
Now, knowing the basic reproductive rate for AIDS and tuberculosis, one can assess the time 
variation of the effective reproductive rate for either infection. It can be noted from equations (29) 
and (30) that the effective reproductive rate for AIDS is dependent on both AIDS and tuberculosis 
prevalence, and the other way around, the effective reproductive rate is also depending on the 
presence of both infections. This is due to the fact that the proportion of remaining susceptible 
varies as a function of both infections. 
DISCUSSION 
The model presented here combines the structures of models previously reported for AIDS [25] 
and for tuberculosis (261 including the complexities resulting from the interaction of two infections. 
It should be clear that our aim is to provide a theoretical framework allowing the analysis of the 
dynamic interaction of two distinct infections on the same host population. This paper intends 
to present the model’s structure and the analysis of its theoretical consistency, and to check 
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whether it fulfils the Pilz and Tautu [27] definition, according to which “the aim of mathematical 
modelling is the examination of natural processes and phenomena in an abstract and logically 
coherent manner.” 
There are several other models for the HIV transmission that could have been chosen to study 
its interaction with tuberculosis. The specialized literature abounds with such models (see a 
recent review by Anderson et al. [21] and every new issue of those periodicals presents a new one. 
On the other hand, there are few models for tuberculosis. Since the seminal papers by Waaler 
et al. [28-301, ReVelle [26], and Azuma [31] in the late sixties and early seventies, few authors 
have addressed this subject. This is probably due to the fact that tuberculosis ceased to be a 
public health problem in the developed countries, despite the fact that this disease has never lost 
its grip of human lives in developing countries. This picture, however, was dramatically reversed 
with the advent of AIDS pandemic. 
Due to its particularities, AIDS is a syndrome characterized by the interaction of HIV with 
other infections. This is particularly true for tuberculosis. It is therefore surprising how few 
works have investigated the dynamics of these interactions. Some exceptions are the papers by 
Kault and March [22], and that by Pepin et al. [32], who proposed a model of AIDS as a function 
of other sexually transmitted diseases, and that a schematic representation for the interactions 
between HIV infection and tropical diseases which has a structure quite similar to our model, 
although these authors do not propose any dynamic model associated with their scheme. 
Biological realities not considered at this stage, like the heterogeneity in sexual contacts, de- 
scribed by Anderson [33], and the likely distributions of HIV incubation periods, described by 
Bhythe and Anderson [34], could be easily incorporated into the model. Also, intervention strate- 
gies, like treatment of active tuberculosis and/or HIV-positive individuals, chemoprophylaxis or 
vaccination against tuberculosis can be included simply by modifying some transition rates or by 
appending new compartments on the model. 
Co-infection is represented by a parallel structure which allows the analysis of either disease 
individually or the concomitant occurrence of both infections, highlighting, therefore their mu- 
tual influence and the qualitatively distinct outcomes that results. This structure demands the 
inclusion of new compartments, which represents the co-infection states, namely Ys, Y,, 12, AZ, 
and ATbc. Note that the first three compartments reproduce the structure proposed for describ- 
ing the dynamics of tuberculosis, in the presence of HIV infection. However, when we consider 
the full-blown AIDS compartments, this structure is simplified, since it is not reasonable to accept 
the evolution of primary TB infection to a latent form of disease in this situation. 
Other compartments representing theoretical possibilities were considered. The fraction of 
individuals infected by HIV and who do not evolve to full-blown AIDS, unless infected by TB, 
represented in the model by the compartment Z(t), although not universally accepted, is a 
possibility that should be considered in a theoretical study like this. The so-called AIDS-Related- 
Complex condition is also questionable from the epidemiological point of view since it evolves to 
full-blown AIDS by the same manner as HIV+ do. It must be noted that the clinical definition 
of AIDS was changed in 1987 [35] and that the use of the ARC diagnosis has been discontinued 
by some medical practitioners. However, ARC diagnosis has not been abandoned and, when 
present, provides additional information. Also, in this case, we consider the possibility of some 
of such individuals remaining as ARC in the absence of a co-infection. Finally, the compartment 
representing HIV+ individuals with active TB, (Y ) 4 may be questioned depending on the AIDS 
definition adopted and on the epidemiological background of the involved population. So, in 
populations with high levels of TB prevalence, it seems reasonable to consider the existence of 
such state. 
The sensitivity analysis pointed to fl as the parameter to which the model is, by far, most 
sensitive. On the other hand, the model showed a very low degree of sensitivity to X, the parameter 
that, along with 0, is associated with the non-linear terms of the model. This is probably due 
to the fact that, contrasting with HIV, there is spontaneous recovery for TB infection. This 
high sensitivity to p is in agreement with current epidemiological expectancies and may help the 
design of control strategies. 
The difference found between the threshold values for p and X may be surprising at first sight 
since the basic reproductive rate is probably greater for TB than for AIDS. It should be remarked 
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that the threshold values found are ones which cause Ro to be greater than one. As the period of 
time individuals spend in the infectious states is much greater for AIDS than TB, the difference 
found is to be expected. The threshold values were calculated from the equilibrium situation in 
which both infections were absent. The same method can be applied for threshold estimations 
with either infection present at equilibrium. The results of such calculations will be reported in 
a future paper. 
The numerical simulations were performed to illustrate the model’s dynamics and resulted in 
three striking outcomes, regarding the mutual influences of both infections. First, the pathogenic- 
ity of HIV is enhanced by the presence of TB, and vice-versa, as shown in Figures 2 and 3. Second, 
the prevalence of AIDS almost doubled in the presence of TB as shown by the lowest line of the 
upper set of curves of Figure 4. It can be noted that further increases in TB incidence correspond 
to increases in AIDS prevalence levels. Figure 5 shows that the increase in HIV incidence levels 
result also in an increase in TB prevalence, although with a distinct pattern. Third, Figures 6 
and 7 show the results of the relative risk analysis and demonstrate clearly that there is a much 
stronger influence of AIDS on TB than the other way around. This aspect may account for the 
differences mentioned above. 
We think the model fulfils its objectives and has proven to be logically coherent, providing 
outcomes that are in accord with current epidemiological expectancies. It could, therefore, be 
used as a template upon which alternative control strategies could be tested, like treatment and 
vaccination schedules. It also provides insights into the epidemiological interaction between AIDS 
and TB, that poses questions that should be tested in the field. This induced us to design a cohort 
study in a South American prison in order to check the model’s outcomes, which will be carried 
out in the near future. 
REFERENCES 
1. P.F. Barnes, A.B. Bloch, P.T. Davidson and D.E. Snider, Jr., Tuberculosis in patients with human immun- 
odeficiency virus infection, New. Engl. J. Med. 324 (3), 1644-1650 (1991). 
2. 1984 tuberculosis statistics: States and cities, Dept. of Health and Human Services Publications (CDC), 
pp. 85-8249, Centers for Disease Control, Atla,nta, GA, (July 1985). 
3. H.L. Rieder, G.M. Cauthen, G.D. Kelly, A.B. Bloch and D.E. Snider, Jr., Tuberculosis in the United States, 
JAMA 268, 3385-3389 (1989). 
4. H.L. Rieder, G.M. Cauthen, G.W. Comstack and D.E. Snider, Jr., Epidemiology of tuberculosis in the 
United States, Epidemiol. Rev. 11, 79-98 (1989). 
5. Update: Tuberculosis elimination-united States, MMWR 39, 153-156 (1990). 
6. Cases of specified notifiable diseases, United States, ending December 29, 1990, and December 30, 1989, 
(52”d week), MMWR 39, 944 (1991). 
7. R.E. Chaisson and G. Slutkin, Tuberculosis and human immunodeficiency virus infection, J. Inject. Dis. 
159, 96-99 (1989). 
8. S. Black, S. Vedal, L.M. Lauson, J. Ruedy and J.S.G. Montaner, AIDS research program: Tuberculosis in 
HIV infected individuals in the province of British Columbia 1983-1988, AIDS gh International Conference, 
Montreal, (1989). 
9. G. Sunderham, R.J. McDonald, T. Maniatis, J. Oleske, R. Kapila and L.B. Reichmann, Tuberculosis as a 
manifestation of the acquired immunodeficiency syndrome (AIDS), JAMA 256, 362-366 (1986). 
10. H.L. Rieder, G.M. Cauthen, A.B. Bloch, C.H. Cole, D. Holtzman, D.E. Snider, Jr., W.J. Bigler and J.J. 
Witte, Tuberculosis and acquired immunodeficiency syndrome-Florida, Arch. Int. Med. 149, 1268-1273 
(1989). 
11. P.A. Selwyn, D. Hartel, V.A. Lewis, E.E. Schoenbaum, S.H. Vernud and R.S. Klein, A prospective study 
of the risk of tuberculosis among intravenous drug abusers with human immunodeficiency virus infection, 
N. Engl. J. Med. 320, 545-550 (1989). 
12. J.M. Fitzgerald, S. Grzybowski and E.A. Allen, The impact of human immunodeficiency virus infection on 
tuberculosis and its control. Chest 100 (l), 191-200 (1991). 
13. C.P. Theuer, P.C. Hopewell, D. Elias, G.F. Schecker, G.W. Rutherford and R.E. Chaisson, Human immun- 
odeficiency virus infection in tuberculosis patients. J. Inject. Dis. 162, 8-12 (1990). 
14. Global Programme on AIDS and Tuberculosis, %berculosis and AIDS: Statement on AIDS and tuberculosis, 
WHOIGPAIINF89.4, (1989). 
15. Advisory Group, Report of the Technical Advisory Meeting on AIDS and Tuberculosis, Geneva, 2-4 August 
1988, Technical Report, WHO, (1989). 
16. K. Styblo, Overview and epidemiological assessment of the current global tuberculosis situation with an 
emphasis on control in developing countries, Rev. Inject. Dis. 11 (suppl. 2), S339-S346 (1989). 
AIDS and tuberculosis 21 
17. N.T.J. Bailey, The Biomathematics of Malaria, 2 “d ed., Chapter 11, pp. 178-182, Charles Griffin & Com- 
pany, Ltd., London and High Wycombe, (1982). 
18. W.H. Press, B.P. Flannery, S.A. Teukolsky and W.T. Vetterling, Numerical Recipes: The Art of Scientific 
Computing, Chapter 9, pp. 254-259, Cambridge University Press, Cambridge, (1989). 
19. R.M. May, Stability and Complexity in Model Ecosystem, 2 “d ed. Chapter 2, pp. 19-26, Princeton University , 
Press, Princeton, New Jersey, (1974). 
20. R.M. Anderson and R.M. May, Vaccination against rubella and measles: Quantitative investigations of 
different policies, J. Hyg. Camb. 90, 259-325 (1983). 
21. R.M. Anderson, R.M. May, M.C. Boily, G.P. Garnett and J.T. Rowley, The spread of HIV-l in Africa sexual 
contact patterns and the predicted demographic impact of AIDS, Nature 352, 581-588 (1991). 
22. D.A. Kault and L.M. Marsh, Modelling AIDS as a function of other sexually transmitted diseases, Math. 
Biosc. 103, 17-31 (1991). 
23. D.G. Kleinbaun, L.L. Kupper and H. Morgenstern, Epidemiologic Research: Principles and Quantitative 
Methods, Chapter 8, pp. 140-158, Van Nostrand Reinhold Company, New York, (1982). 
24. H. Morgenstern, D.G. Kleibaun and L.L. Kupper, Measures of disease incidence used in epidemiologic 
research, Int. J. Epidemiol. 9, 97-104 (1980). 
25. E. Massad, A homogeneity mixing model for the AIDS epidemic, Mathl. Comput. Modelling 12 (l), 89-96 
(1989). 
26. C.S. Revelle, W.R. Lynn and F. Feldman, Mathematical models for the economic allocation of tuberculosis 
control activities in developing nations, Am. Rev. Resp. Dis. 96, 893-909 (1967). 
27. L. Pilz and P. Tautu, Causality and validation of mathematical models, Meth. Inj. Med. 27, 153-154 (1988). 
28. H.T. Waaler, A dynamic model for the epidemiology of tuberculosis, Am. Rev. Resp. Dis. 98, 591-600 
(1968). 
29. H.T. Waaler and M.A. Piot, The use of an epidemiological model for estimating the effectiveness of tuber- 
culosis control measures: Sensitivity of the effectiveness of tuberculosis control measures to the coverage of 
the population, Bull WHO 41, 75-93 (1969). 
30. H.T. Waaler, A. Geeser and S. Anderson, The use of mathematical models in the study of the epidemiology 
of tuberculosis, A JPH 52, 1002-1013 (1962). 
31. Y. Azuma, A simple simulation model of tuberculosis epidemiology for use without large-scale computers, 
Bull. WHO 52, 313-322 (1975). 
32. J. Pepin, The interaction of HIV infection and other sexually transmitted diseases: An opportunity for 
intervention, AIDS 3, 3-9 (1989). 
33. R.M. Anderson, The epidemiology of HIV infection: Variable incubation plus infections period and hetero- 
geneity in sexual activity, J.R. Stat. Sot. A 151, 66-93 (1988). 
34. S.P. Blythe and R.M. Anderson, Distributed incubation and infectious periods in models of the transmission 
dynamics of the human immunodeficiency virus (HIV), IMA J. Math. Med. Bio. 5, 1-19 (1988). 
35. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome, MMWR 36 
(suppl. 15), 35-155 (1987). 
36. P.G. Smith, R.H. Morrow and J. Chin, Investigating interactions between HIV infection and tropical diseases, 
Int. J. Epidemiol. 17 (4), 705-707 (1988). 
